This article endeavors to explore the current development status of an all-round and full-cycle health management model for cancer and provide strategic recommendations to address future challenges, in support of the realization of China's ‘Healthy China 2030’strategic plan. Building upon an analysis of the current status of cancer diagnosis, treatment, and prevention and control management in China, the article combines the new trends, missions, and demands in cancer care to propose the developmental trajectory of China's cancer diagnosis and treatment model. This trajectory shifts from a disease-centered multidisciplinary approach to a patient-centered all-round and full-cycle health management at the present stage. This article further delves into the characteristics and shortcomings of the current cancer diagnosis, treatment, and prevention and control system in China, and puts forward corresponding recommendations. These recommendations include enhancing the focus and investment in prevention and screening, standardizing cancer diagnosis and treatment protocols and quality control, prioritizing improvements in patient quality of life, and promoting the development of accessible and intelligent medical services.
LI Lixi
,
MA Fei
. The development status and future challenges of the all-round and full-cycle health management model of cancer[J]. Science & Technology Review, 2023
, 41(18)
: 29
-35
.
DOI: 10.3981/j.issn.1000-7857.2023.18.004
[1] Siegel R L, Miller K D, Wagle N S, et al. Cancer statistics, 2023[J]. Ca-A Cancer Journal For Clinicians, 2023, 73(1): 17-48.
[2] 郑荣寿, 张思维, 孙可欣, 等. 2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2023, 45(3): 212-220.
[3] Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016[J]. Journal of the National Cancer Center, 2022, 2(1): 1-9.
[4] 石远凯, 孙燕. 中国抗肿瘤新药临床试验60年发展历程和主要成果(1960—2020)[J]. 中华肿瘤杂志, 2021, 43(6): 696-706.
[5] 乔延伟 . 肿瘤精确放疗技术发展及应用现状[J]. 中国医疗设备, 2014(7): 73-76.
[6] 苏闫兵 . 肿瘤多学科诊疗研究的演进趋势与特征分析[D]. 太原: 山西医科大学, 2021.
[7] 崔铭, 廖泉, 赵玉沛. 胰腺肿瘤的多学科诊疗模式[J]. 中华内分泌外科杂志, 2017, 11(6): 441-443.
[8] 孙燕, 殷蔚伯, 王奇璐, 等 . 肺癌非手术综合治疗 233例分析[J]. 中华结核和呼吸系疾病杂志, 1983, 6(1): 14-18.
[9] 国家肿瘤质控中心乳腺癌专家委员会, 中国抗癌协会乳腺癌专业委员会, 中国抗癌协会肿瘤药物临床研究专业委员会 . 中国晚期乳腺癌规范诊疗指南(2022 版)[J]. 中华肿瘤杂志, 2022(12): 1262-1287.
[10] 中华人民共和国国家卫生健康委员会 . 原发性肺癌诊疗指南(2022 年版)[J]. 中国合理用药探索, 2022(9): 1-28.
[11] 中华人民共和国国家卫生健康委员会, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2023年版)[J]. 中华外科杂志, 2023, 61(8): 617-644.
[12] 王志峰, 廖国龙, 欧阳鹏, 等 . 恶性肿瘤晚期患者心理问题的影响因素分析[J]. 中国现代药物应用, 2023, 17(1): 41-44.
[13] 黎立喜, 马飞 . 乳腺癌全方位和全周期的健康管理模式[J]. 中国医学前沿杂志(电子版), 2020(3): 1-5.
[14] 徐兰, 夏爽, 黎励文 . 肿瘤心脏病学: 交叉学科的机遇与挑战[J]. 中华心血管病杂志, 2021(2): 198-204.
[15] 卢光琇, 杨晓祎 . 肿瘤生殖学——一门崭新的交叉学科[J]. 国际生殖健康/计划生育杂志, 2012(5): 341-343.
[16] 丁小强, 陈晓泓. 肿瘤肾脏病学: 交叉学科的机遇与挑战[J]. 上海医学, 2021(9): 628-632.
[17] Oeffinger K C, Fontham E T, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society[J]. JAMA, 2015, 314(15): 1599-1614.
[18] Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: A pooled analysis of 17 population-based cancer registries[J]. Lancet Global Health, 2018, 6(5): 555-567.
[19] 中国共产党中央委员会, 中华人民共和国国务院 .“健康中国 2030”规划纲要[J]. 中国实用乡村医生杂志, 2017, 24(7): 1-12.
[20] Li N, Huang H Y, Wu D W, et al. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: A systematic review[J]. Lancet Oncology, 2019, 20(11): 619-626.
[21] Huang H, Wu D, Miao H, et al. Accelerating the integration of China into the global development of innovative anticancer drugs[J]. Lancet Oncology, 2022, 23(11): 515-520.
[22] LeBlanc T W, Abernethy A P. Patient-reported outcomes in cancer care-hearing the patient voice at greater volume[J]. Nature Reviews Clinical Oncolog, 2017, 14(12): 763-772.
[23] Brady K J S, Peipert J D, Atkinson T M, et al. International society for quality of life research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials[J]. Quality of Life Research, 2023, 32(8): 2155-2163.
[24] 国家药品监督管理局 . 患者报告结局在药物临床研发中应用的指导原则(试行)[J]. [2021-11-27]. https://wwwcdeorgcn/main/news/viewInfoCommon/2f79c22e8678241b030c71523eb300c.
[25] Zhou H, Yao M, Gu X, et al. Application of patient-reported outcome measurements in clinical trials in China[J]. JAMA Network Open, 2022, 5(5): e2211644.
[26] 杨煦, 陈京, 刘巍, 等 . 肿瘤专科医院日间病房诊疗模式 的 建 立 与 管 理 [J]. 中 国 医 学 前 沿 杂 志 (电 子 版), 2021, 13(5): 2-5.
[27] 中国肿瘤日间诊疗协作组 . 中国恶性肿瘤日间诊疗专家共识(2022 版)[J]. 中华肿瘤杂志, 2022, 44(4): 307-320.
